The novel GLP-1 / GIP dual agonist DA3-CH is more effective than liraglutide in the MPTP mouse model of Parkinson's disease
Peng Feng, Zewei Liu, DongLiang Lv, WanDa Hao, DongFang Li, Guofang Xue, Bo Bai, Christian Hölscher
Topics & Concepts
LiraglutideMPTPAgonistParkinson's diseaseMedicineEndocrinologyDiseaseInternal medicinePharmacologyType 2 diabetesNeuroscienceDiabetes mellitusPsychologyReceptorDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerAmino Acid Enzymes and Metabolism